{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:01:25Z","timestamp":1784581285940,"version":"3.55.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02216-1","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:52:49Z","timestamp":1781772769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineered small extracellular vesicles in hematologic malignancies: mechanisms, therapeutic strategies, and translational challenges"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7105-1161","authenticated-orcid":false,"given":"Chou-Yi","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidmurodkhon","family":"Murtazaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally Hassan","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abohassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pareshkumar N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8421-3630","authenticated-orcid":false,"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa Khudhair","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"9","key":"2216_CR1","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.31557\/APJCP.2022.23.9.2881","volume":"23","author":"MM Alnaeem","year":"2022","unstructured":"Alnaeem MM, Bawadi HA. Systematic Review and Meta-Synthesis about Patients with Hematological Malignancy and Palliative Care. Asian Pac J Cancer Prev. 2022;23(9):2881\u201390.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"2216_CR2","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia"},{"key":"2216_CR3","doi-asserted-by":"crossref","unstructured":"Kibler CE, Chabot-Richards DS. Molecular Pathology of Leukemia, in Molecular Surgical Pathology, L. Cheng, G.J. Netto, and J.N. Eble, Editors. 2023, Springer International Publishing: Cham. pp. 681\u2013709.","DOI":"10.1007\/978-3-031-35118-1_25"},{"key":"2216_CR4","first-page":"p0948","volume":"8","author":"B Huang","year":"2025","unstructured":"Huang B, et al. Chronic Psychological Stress in Oncogenesis: Multisystem Crosstalk and Multimodal Interventions. Res (Wash D C). 2025;8:p0948.","journal-title":"Res (Wash D C)"},{"issue":"3","key":"2216_CR5","doi-asserted-by":"publisher","first-page":"e536","DOI":"10.1097\/HS9.0000000000000536","volume":"5","author":"P Valent","year":"2021","unstructured":"Valent P, et al. Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions. Hemasphere. 2021;5(3):e536.","journal-title":"Hemasphere"},{"issue":"2","key":"2216_CR6","doi-asserted-by":"publisher","first-page":"108557","DOI":"10.1016\/j.cclet.2023.108557","volume":"35","author":"L Guo","year":"2024","unstructured":"Guo L, Ding J, Zhou W. Harnessing bacteria for tumor therapy: Current advances and challenges. Chin Chem Lett. 2024;35(2):108557.","journal-title":"Chin Chem Lett"},{"issue":"15","key":"2216_CR7","doi-asserted-by":"publisher","first-page":"e2103222","DOI":"10.1002\/advs.202103222","volume":"9","author":"JJ Lai","year":"2022","unstructured":"Lai JJ, et al. Exosome Processing and Characterization Approaches for Research and Technology Development. Adv Sci (Weinh). 2022;9(15):e2103222.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"2216_CR8","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2216_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","volume":"371","author":"R Munagala","year":"2016","unstructured":"Munagala R, et al. Bovine milk-derived exosomes for drug delivery. Cancer Lett. 2016;371(1):48\u201361.","journal-title":"Cancer Lett"},{"issue":"6","key":"2216_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12032-025-02742-0","volume":"42","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, et al. Mesenchymal stem cell-derived exosomes: a novel therapeutic frontier in hematological disorders. Med Oncol. 2025;42(6):199.","journal-title":"Med Oncol"},{"key":"2216_CR11","doi-asserted-by":"publisher","first-page":"155785","DOI":"10.1016\/j.prp.2024.155785","volume":"266","author":"AK Balaraman","year":"2025","unstructured":"Balaraman AK, et al. Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing. Pathol - Res Pract. 2025;266:155785.","journal-title":"Pathol - Res Pract"},{"issue":"1","key":"2216_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12645-025-00334-1","volume":"16","author":"M Rahgoshay","year":"2025","unstructured":"Rahgoshay M, et al. Engineered exosomes: advanced nanocarriers for targeted therapy and drug delivery in hematological malignancies. Cancer Nanotechnol. 2025;16(1):33.","journal-title":"Cancer Nanotechnol"},{"issue":"18","key":"2216_CR13","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1182\/bloodadvances.2023012464","volume":"8","author":"S Yuan","year":"2024","unstructured":"Yuan S, et al. Anti-BCMA-engineered exosomes for bortezomib-targeted delivery in multiple myeloma. Blood Adv. 2024;8(18):4886\u201399.","journal-title":"Blood Adv"},{"issue":"8","key":"2216_CR14","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1007\/s00259-022-05696-x","volume":"49","author":"R Qian","year":"2022","unstructured":"Qian R, et al. Multi-antitumor therapy and synchronous imaging monitoring based on exosome. Eur J Nucl Med Mol Imaging. 2022;49(8):2668\u201381.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2216_CR15","doi-asserted-by":"publisher","first-page":"114974","DOI":"10.1016\/j.addr.2023.114974","volume":"199","author":"ZF Greenberg","year":"2023","unstructured":"Greenberg ZF, Graim KS, He M. Towards artificial intelligence-enabled extracellular vesicle precision drug delivery. Adv Drug Deliv Rev. 2023;199:114974.","journal-title":"Adv Drug Deliv Rev"},{"key":"2216_CR16","doi-asserted-by":"crossref","unstructured":"Youssef E et al. Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics. Cancers (Basel), 2025. 17(6).","DOI":"10.3390\/cancers17060940"},{"issue":"2","key":"2216_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ddc4020019","volume":"4","author":"T Premchandani","year":"2025","unstructured":"Premchandani T, et al. Engineered Exosomes as Smart Drug Carriers: Overcoming Biological Barriers in CNS and Cancer Therapy. Drugs Drug Candidates. 2025;4(2):19.","journal-title":"Drugs Drug Candidates"},{"key":"2216_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, et al. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9:19.","journal-title":"Cell Biosci"},{"issue":"3","key":"2216_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","volume":"49","author":"I Wortzel","year":"2019","unstructured":"Wortzel I, et al. Exosome-Mediated Metastasis: Communication from a Distance. Dev Cell. 2019;49(3):347\u201360.","journal-title":"Dev Cell"},{"issue":"2","key":"2216_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871(2):455\u201368.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2216_CR21","doi-asserted-by":"publisher","first-page":"11611","DOI":"10.2147\/IJN.S479697","volume":"19","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Recent Progress of Exosomes in Hematological Malignancies: Pathogenesis, Diagnosis, and Therapeutic Strategies. Int J Nanomed. 2024;19:11611\u201331.","journal-title":"Int J Nanomed"},{"key":"2216_CR22","doi-asserted-by":"crossref","unstructured":"Meng Q et al. Metabolic Messengers: Extracellular Vesicles as Central Mediators of Metabolic Reprogramming in Renal Cell Cancer. Biomedicines, 2026. 14(2).","DOI":"10.3390\/biomedicines14020282"},{"key":"2216_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cytogfr.2023.08.010","volume":"73","author":"Y Xi","year":"2023","unstructured":"Xi Y, et al. Exosome-mediated metabolic reprogramming: Implications in esophageal carcinoma progression and tumor microenvironment remodeling. Cytokine Growth Factor Rev. 2023;73:78\u201392.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"2216_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41392-020-00359-5","volume":"5","author":"E Yang","year":"2020","unstructured":"Yang E, et al. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduct Target Therapy. 2020;5(1):242.","journal-title":"Signal Transduct Target Therapy"},{"issue":"23","key":"2216_CR25","doi-asserted-by":"publisher","first-page":"9621","DOI":"10.1158\/0008-5472.CAN-10-1722","volume":"70","author":"J Webber","year":"2010","unstructured":"Webber J, et al. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 2010;70(23):9621\u201330.","journal-title":"Cancer Res"},{"issue":"8","key":"2216_CR26","doi-asserted-by":"publisher","first-page":"e1800148","DOI":"10.1002\/pmic.201800148","volume":"19","author":"A Rai","year":"2019","unstructured":"Rai A, et al. Exosomes Derived from Human Primary and Metastatic Colorectal Cancer Cells Contribute to Functional Heterogeneity of Activated Fibroblasts by Reprogramming Their Proteome. Proteomics. 2019;19(8):e1800148.","journal-title":"Proteomics"},{"issue":"2","key":"2216_CR27","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1159\/000488635","volume":"46","author":"X Ma","year":"2018","unstructured":"Ma X, et al. Loading MiR-210 in Endothelial Progenitor Cells Derived Exosomes Boosts Their Beneficial Effects on Hypoxia\/Reoxygeneation-Injured Human Endothelial Cells via Protecting Mitochondrial Function. Cell Physiol Biochem. 2018;46(2):664\u201375.","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"2216_CR28","doi-asserted-by":"publisher","first-page":"10602","DOI":"10.1002\/jcp.27735","volume":"234","author":"B Wang","year":"2019","unstructured":"Wang B, et al. Exosomes derived from acute myeloid leukemia cells promote chemoresistance by enhancing glycolysis-mediated vascular remodeling. J Cell Physiol. 2019;234(7):10602\u201314.","journal-title":"J Cell Physiol"},{"issue":"8","key":"2216_CR29","first-page":"1815","volume":"9","author":"C Yang","year":"2019","unstructured":"Yang C, et al. Focus on exosomes: novel pathogenic components of leukemia. Am J Cancer Res. 2019;9(8):1815\u201329.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2216_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10456-011-9241-1","volume":"15","author":"M Mineo","year":"2012","unstructured":"Mineo M, et al. Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis. 2012;15(1):33\u201345.","journal-title":"Angiogenesis"},{"issue":"48","key":"2216_CR31","doi-asserted-by":"publisher","first-page":"34343","DOI":"10.1074\/jbc.M113.480822","volume":"288","author":"H Tadokoro","year":"2013","unstructured":"Tadokoro H, et al. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013;288(48):34343\u201351.","journal-title":"J Biol Chem"},{"issue":"1","key":"2216_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12929-025-01182-2","volume":"32","author":"NY Yeat","year":"2025","unstructured":"Yeat NY, Chen RH. Extracellular vesicles: biogenesis mechanism and impacts on tumor immune microenvironment. J Biomed Sci. 2025;32(1):85.","journal-title":"J Biomed Sci"},{"issue":"4","key":"2216_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/bcr2892","volume":"13","author":"F Sotgia","year":"2011","unstructured":"Sotgia F, et al. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res. 2011;13(4):213.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2216_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s10020-025-01205-6","volume":"31","author":"W Zhang","year":"2025","unstructured":"Zhang W, et al. Warburg effect and lactylation in cancer: mechanisms for chemoresistance. Mol Med. 2025;31(1):146.","journal-title":"Mol Med"},{"key":"2216_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cytogfr.2023.07.004","volume":"73","author":"M Vahabi","year":"2023","unstructured":"Vahabi M, et al. Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism. Cytokine Growth Factor Rev. 2023;73:163\u201372.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2216_CR36","doi-asserted-by":"publisher","first-page":"104175","DOI":"10.1016\/j.exphem.2024.104175","volume":"133","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Li Z, Xi Y. EV-mediated intercellular communication in acute myeloid leukemia: Transport of genetic materials in the bone marrow microenvironment. Exp Hematol. 2024;133:104175.","journal-title":"Exp Hematol"},{"issue":"11","key":"2216_CR37","doi-asserted-by":"publisher","first-page":"104161","DOI":"10.1016\/j.drudis.2024.104161","volume":"29","author":"Y Guo","year":"2024","unstructured":"Guo Y, et al. P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators. Drug Discovery Today. 2024;29(11):104161.","journal-title":"Drug Discovery Today"},{"key":"2216_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.leukres.2017.09.014","volume":"62","author":"C Bouvy","year":"2017","unstructured":"Bouvy C, et al. Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo. Leuk Res. 2017;62:70\u20136.","journal-title":"Leuk Res"},{"issue":"5","key":"2216_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/biom15050685","volume":"15","author":"G Liu","year":"2025","unstructured":"Liu G, et al. Exosome-Mediated Chemoresistance in Cancers: Mechanisms, Therapeutic Implications, and Future Directions. Biomolecules. 2025;15(5):685.","journal-title":"Biomolecules"},{"key":"2216_CR40","doi-asserted-by":"crossref","unstructured":"Pavlic A et al. Inhibition of Neutral Sphingomyelinase 2 by Novel Small Molecule Inhibitors Results in Decreased Release of Extracellular Vesicles by Vascular Smooth Muscle Cells and Attenuated Calcification. Int J Mol Sci, 2023. 24(3).","DOI":"10.3390\/ijms24032027"},{"issue":"1","key":"2216_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","volume":"21","author":"D Yu","year":"2022","unstructured":"Yu D, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21(1):56.","journal-title":"Mol Cancer"},{"issue":"1","key":"2216_CR42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, et al. Liquid biopsy in cancer: current status, challenges and future prospects. Signal Transduct Target Therapy. 2024;9(1):336.","journal-title":"Signal Transduct Target Therapy"},{"key":"2216_CR43","doi-asserted-by":"crossref","unstructured":"Irmer B et al. Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors. Cancers (Basel), 2023. 15(4).","DOI":"10.3390\/cancers15041307"},{"key":"2216_CR44","doi-asserted-by":"crossref","unstructured":"Zhu H et al. Liquid Biopsy in Early Screening of Cancers: Emerging Technologies and New Prospects. Biomedicines, 2026. 14(1).","DOI":"10.3390\/biomedicines14010158"},{"key":"2216_CR45","doi-asserted-by":"publisher","first-page":"viii658","DOI":"10.1093\/annonc\/mdy303.029","volume":"29","author":"H Ryu","year":"2018","unstructured":"Ryu H, et al. Proteomic-based machine learning computational analysis discovered biomarkers of aberrant vesicle-exosomal trafficking to determine chemotherapeutic responses in breast cancer. Ann Oncol. 2018;29:viii658\u20139.","journal-title":"Ann Oncol"},{"issue":"4","key":"2216_CR46","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/aps.2017.178","volume":"39","author":"S-p Li","year":"2018","unstructured":"Li S-p, et al. Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools. Acta Pharmacol Sin. 2018;39(4):542\u201351.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"2216_CR47","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1124\/pharmrev.123.000841","volume":"75","author":"SI van de Wakker","year":"2023","unstructured":"van de Wakker SI, et al. Extracellular Vesicle Heterogeneity and Its Impact for Regenerative Medicine Applications. Pharmacol Rev. 2023;75(5):1043\u201361.","journal-title":"Pharmacol Rev"},{"key":"2216_CR48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jconrel.2024.02.015","volume":"368","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy. J Controlled Release. 2024;368:170\u201383.","journal-title":"J Controlled Release"},{"key":"2216_CR49","doi-asserted-by":"publisher","first-page":"114243","DOI":"10.1016\/j.matdes.2025.114243","volume":"256","author":"K Deng","year":"2025","unstructured":"Deng K, et al. Harnessing engineered exosomes for transformative therapy of cardiovascular and cerebrovascular disorders: Opportunities and challenges. Mater Design. 2025;256:114243.","journal-title":"Mater Design"},{"key":"2216_CR50","doi-asserted-by":"publisher","first-page":"100148","DOI":"10.1016\/j.mtnano.2021.100148","volume":"16","author":"BS Joshi","year":"2021","unstructured":"Joshi BS, Ortiz D, Zuhorn IS. Converting extracellular vesicles into nanomedicine: loading and unloading of cargo. Mater Today Nano. 2021;16:100148.","journal-title":"Mater Today Nano"},{"key":"2216_CR51","doi-asserted-by":"crossref","unstructured":"Han Y et al. Overview and Update on Methods for Cargo Loading into Extracellular Vesicles. Processes (Basel), 2021. 9(2).","DOI":"10.3390\/pr9020356"},{"issue":"46","key":"2216_CR52","doi-asserted-by":"publisher","first-page":"43374","DOI":"10.1021\/acsomega.3c04479","volume":"8","author":"L Huang","year":"2023","unstructured":"Huang L, et al. Research Advances of Engineered Exosomes as Drug Delivery Carrier. ACS Omega. 2023;8(46):43374\u201387.","journal-title":"ACS Omega"},{"issue":"1","key":"2216_CR53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","volume":"172","author":"SAA Kooijmans","year":"2013","unstructured":"Kooijmans SAA, et al. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Control Release. 2013;172(1):229\u201338.","journal-title":"J Control Release"},{"issue":"1","key":"2216_CR54","doi-asserted-by":"publisher","first-page":"2562224","DOI":"10.1080\/10717544.2025.2562224","volume":"32","author":"M Singh","year":"2025","unstructured":"Singh M, et al. Electroporation induced changes in extracellular vesicle profile. Drug Deliv. 2025;32(1):2562224.","journal-title":"Drug Deliv"},{"key":"2216_CR55","doi-asserted-by":"crossref","unstructured":"Dieu LL, Kazsoki A, Zelk\u00f3 R. Drug-Loaded Extracellular Vesicle-Based Drug Delivery: Advances, Loading Strategies, Therapeutic Applications, and Clinical Challenges. Pharmaceutics, 2025. 18(1).","DOI":"10.3390\/pharmaceutics18010045"},{"issue":"4","key":"2216_CR56","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, et al. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024;56(4):836\u201349.","journal-title":"Exp Mol Med"},{"key":"2216_CR57","doi-asserted-by":"publisher","first-page":"113664","DOI":"10.1016\/j.jconrel.2025.113664","volume":"382","author":"J Yang","year":"2025","unstructured":"Yang J, et al. Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering. J Control Release. 2025;382:113664.","journal-title":"J Control Release"},{"key":"2216_CR58","doi-asserted-by":"publisher","first-page":"160915","DOI":"10.1016\/j.cej.2025.160915","volume":"512","author":"N Mukerjee","year":"2025","unstructured":"Mukerjee N, et al. Click chemistry-based modified exosomes: Towards enhancing precision in cancer theranostics. Chem Eng J. 2025;512:160915.","journal-title":"Chem Eng J"},{"key":"2216_CR59","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.2147\/IJN.S464249","volume":"19","author":"M Bahadorani","year":"2024","unstructured":"Bahadorani M, et al. Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies. Int J Nanomed. 2024;19:7137\u201364.","journal-title":"Int J Nanomed"},{"issue":"7","key":"2216_CR60","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, et al. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183\u201395.","journal-title":"Theranostics"},{"issue":"1","key":"2216_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12951-020-00746-8","volume":"19","author":"B Jing","year":"2021","unstructured":"Jing B, et al. Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT\/NIRF imaging of colon cancer. J Nanobiotechnol. 2021;19(1):7.","journal-title":"J Nanobiotechnol"},{"key":"2216_CR62","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jcis.2023.07.018","volume":"650","author":"A Ridolfi","year":"2023","unstructured":"Ridolfi A, et al. Electrostatic interactions control the adsorption of extracellular vesicles onto supported lipid bilayers. J Colloid Interface Sci. 2023;650:883\u201391.","journal-title":"J Colloid Interface Sci"},{"issue":"6","key":"2216_CR63","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10585-024-10305-2","volume":"41","author":"MH Elbahoty","year":"2024","unstructured":"Elbahoty MH, Papineni B, Samant RS. Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics. Clin Exp Metastasis. 2024;41(6):829\u201342.","journal-title":"Clin Exp Metastasis"},{"key":"2216_CR64","doi-asserted-by":"publisher","first-page":"m3176","DOI":"10.1136\/bmj.m3176","volume":"370","author":"UA Shah","year":"2020","unstructured":"Shah UA, Mailankody S. Emerging immunotherapies in multiple myeloma. BMJ. 2020;370:m3176.","journal-title":"BMJ"},{"issue":"4","key":"2216_CR65","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.apsb.2018.03.001","volume":"8","author":"Z Zhao","year":"2018","unstructured":"Zhao Z, et al. The application of CAR-T cell therapy in hematological malignancies: advantages and challenges. Acta Pharm Sin B. 2018;8(4):539\u201351.","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"2216_CR66","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1111\/j.1582-4934.2009.00851.x","volume":"14","author":"Y Xie","year":"2010","unstructured":"Xie Y, et al. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J Cell Mol Med. 2010;14(11):2655\u201366.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2216_CR67","doi-asserted-by":"publisher","first-page":"e684","DOI":"10.1002\/ctm2.684","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Splicing factor arginine\/serine-rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome-based cellular communication. Clin Transl Med. 2022;12(2):e684.","journal-title":"Clin Transl Med"},{"key":"2216_CR68","doi-asserted-by":"crossref","unstructured":"Fleischmann M et al. Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives. Cancers (Basel), 2021. 13(22).","DOI":"10.3390\/cancers13225722"},{"key":"2216_CR69","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.2147\/IJN.S511713","volume":"20","author":"C Li","year":"2025","unstructured":"Li C, et al. Human Mesenchymal Stem Cell-Derived Exosomes as Engineering Vehicles of Daunorubicin for Targeted c-Mpl\u2009+\u2009AML Therapy. Int J Nanomed. 2025;20:5267\u201389.","journal-title":"Int J Nanomed"},{"issue":"3","key":"2216_CR70","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ymthe.2025.01.025","volume":"33","author":"L Zhang","year":"2025","unstructured":"Zhang L, et al. Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemia. Mol Ther. 2025;33(3):1091\u2013104.","journal-title":"Mol Ther"},{"key":"2216_CR71","doi-asserted-by":"crossref","unstructured":"Liu Y et al. Engineered red blood cell extracellular vesicles for delivery of Dox and siIDO1 enhance targeted chemo-immunotherapy of acute myeloid leukemia. J Immunother Cancer, 2025. 13(7).","DOI":"10.1136\/jitc-2024-011148"},{"issue":"1","key":"2216_CR72","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s12951-025-03588-4","volume":"23","author":"W Wang","year":"2025","unstructured":"Wang W, et al. USP5 inhibition via bone marrow-targeted engineered exosomes for myeloproliferative neoplasms therapy. J Nanobiotechnol. 2025;23(1):501.","journal-title":"J Nanobiotechnol"},{"key":"2216_CR73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semcancer.2013.08.011","volume":"24","author":"JA Burger","year":"2014","unstructured":"Burger JA, Gribben JG. The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies. Semin Cancer Biol. 2014;24:71\u201381.","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"2216_CR74","doi-asserted-by":"publisher","first-page":"e25294","DOI":"10.1371\/journal.pone.0025294","volume":"6","author":"R Ruiss","year":"2011","unstructured":"Ruiss R, et al. EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells\u2013a new option for the treatment of B-CLL. PLoS ONE. 2011;6(10):e25294.","journal-title":"PLoS ONE"},{"issue":"Supplement 1","key":"2216_CR75","first-page":"5561","volume":"130","author":"H Bao","year":"2017","unstructured":"Bao H, et al. Chimeric Antigen Receptor-Engineered Exosome As a Drug Delivery System in Mantle Cell Lymphoma. Blood. 2017;130(Supplement 1):5561\u20135561.","journal-title":"Blood"},{"issue":"1","key":"2216_CR76","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-024-02057-0","volume":"23","author":"X Wu","year":"2024","unstructured":"Wu X, et al. Unveiling the PDK4-centered rituximab-resistant mechanism in DLBCL: the potential of the Smart exosome nanoparticle therapy. Mol Cancer. 2024;23(1):144.","journal-title":"Mol Cancer"},{"key":"2216_CR77","doi-asserted-by":"crossref","unstructured":"Lenna\u00e1rd AJ et al. Optimised Electroporation for Loading of Extracellular Vesicles with Doxorubicin. Pharmaceutics, 2021. 14(1).","DOI":"10.3390\/pharmaceutics14010038"},{"issue":"5","key":"2216_CR78","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s10616-016-9952-7","volume":"68","author":"KB Johnsen","year":"2016","unstructured":"Johnsen KB, et al. Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes. Cytotechnology. 2016;68(5):2125\u201338.","journal-title":"Cytotechnology"},{"issue":"5","key":"2216_CR79","doi-asserted-by":"publisher","first-page":"e15674","DOI":"10.1016\/j.heliyon.2023.e15674","volume":"9","author":"S Colja","year":"2023","unstructured":"Colja S, et al. Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles. Heliyon. 2023;9(5):e15674.","journal-title":"Heliyon"},{"key":"2216_CR80","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.vesic.2024.100052","volume":"4","author":"Y Chen","year":"2024","unstructured":"Chen Y, et al. Ultrasonication outperforms electroporation for extracellular vesicle cargo depletion. Extracell Vesicle. 2024;4:100052.","journal-title":"Extracell Vesicle"},{"issue":"1","key":"2216_CR81","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s13287-024-04005-7","volume":"15","author":"S Ahmadian","year":"2024","unstructured":"Ahmadian S, et al. Different storage and freezing protocols for extracellular vesicles: a systematic review. Stem Cell Res Ther. 2024;15(1):453.","journal-title":"Stem Cell Res Ther"},{"key":"2216_CR82","first-page":"500","volume":"25","author":"D Zheng","year":"2023","unstructured":"Zheng D, et al. Advances in extracellular vesicle functionalization strategies for tissue regeneration. Bioact Mater. 2023;25:500\u201326.","journal-title":"Bioact Mater"},{"issue":"6","key":"2216_CR83","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"Luan X, et al. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38(6):754\u201363.","journal-title":"Acta Pharmacol Sin"},{"key":"2216_CR84","doi-asserted-by":"publisher","first-page":"100261","DOI":"10.1016\/j.impact.2020.100261","volume":"20","author":"S Fu","year":"2020","unstructured":"Fu S, et al. Exosome engineering: Current progress in cargo loading and targeted delivery. NanoImpact. 2020;20:100261.","journal-title":"NanoImpact"},{"key":"2216_CR85","doi-asserted-by":"crossref","unstructured":"McAndrews KM et al. Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer. Life Sci alliance, 2021. 4(9).","DOI":"10.26508\/lsa.202000875"},{"issue":"14Supplement","key":"2216_CR86","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1158\/1538-7445.AM2016-2167","volume":"76","author":"N Yim","year":"2016","unstructured":"Yim N, et al. Efficient and rapid cellular delivery of bioactive proteins using EXPLOR: exosomes engineered for protein loading via optically reversible protein-protein interaction. Cancer Res. 2016;76(14Supplement):2167\u20132167.","journal-title":"Cancer Res"},{"key":"2216_CR87","doi-asserted-by":"crossref","unstructured":"Tomasik J, Jasi\u0144ski M, Basak GW. Next generations of CAR-T cells - new therapeutic opportunities in hematology? Front Immunol, 2022. Volume 13\u20132022.","DOI":"10.3389\/fimmu.2022.1034707"},{"issue":"26","key":"2216_CR88","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","volume":"127","author":"JN Brudno","year":"2016","unstructured":"Brudno JN, Kochenderfer JN. Toxicities of chimeric antigen receptor T cells: recognition and management. Blood. 2016;127(26):3321\u201330.","journal-title":"Blood"},{"key":"2216_CR89","doi-asserted-by":"publisher","first-page":"868695","DOI":"10.3389\/fphar.2022.868695","volume":"13","author":"SK Kim","year":"2022","unstructured":"Kim SK, Cho SW. The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment. Front Pharmacol. 2022;13:868695.","journal-title":"Front Pharmacol"},{"key":"2216_CR90","doi-asserted-by":"publisher","first-page":"113392","DOI":"10.1016\/j.intimp.2024.113392","volume":"144","author":"DY Sun","year":"2025","unstructured":"Sun DY, et al. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies. Int Immunopharmacol. 2025;144:113392.","journal-title":"Int Immunopharmacol"},{"key":"2216_CR91","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/bs.mcb.2021.06.017","volume":"167","author":"C Wang","year":"2022","unstructured":"Wang C, et al. Generation and functional characterization of CAR exosomes. Methods Cell Biol. 2022;167:123\u201331.","journal-title":"Methods Cell Biol"},{"issue":"16","key":"2216_CR92","doi-asserted-by":"publisher","first-page":"13959","DOI":"10.1021\/acs.jmedchem.4c00753","volume":"67","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, et al. Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate. J Med Chem. 2024;67(16):13959\u201374.","journal-title":"J Med Chem"},{"key":"2216_CR93","doi-asserted-by":"crossref","unstructured":"Haque S, Vaiselbuh SR. CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity. Cancers (Basel), 2021. 13(6).","DOI":"10.3390\/cancers13061401"},{"key":"2216_CR94","doi-asserted-by":"publisher","first-page":"104262","DOI":"10.1016\/j.cellimm.2020.104262","volume":"360","author":"P Yang","year":"2021","unstructured":"Yang P, et al. The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth. Cell Immunol. 2021;360:104262.","journal-title":"Cell Immunol"},{"key":"2216_CR95","doi-asserted-by":"publisher","first-page":"1130033","DOI":"10.3389\/fimmu.2023.1130033","volume":"14","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, et al. T cell-derived exosomes in tumor immune modulation and immunotherapy. Front Immunol. 2023;14:1130033.","journal-title":"Front Immunol"},{"issue":"6","key":"2216_CR96","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jcyt.2023.01.005","volume":"25","author":"K Si","year":"2023","unstructured":"Si K, et al. Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering. Cytotherapy. 2023;25(6):615\u201324.","journal-title":"Cytotherapy"},{"key":"2216_CR97","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jconrel.2020.07.033","volume":"326","author":"Q Xu","year":"2020","unstructured":"Xu Q, et al. Tropism-facilitated delivery of CRISPR\/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies. J Control Release. 2020;326:455\u201367.","journal-title":"J Control Release"},{"issue":"10","key":"2216_CR98","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/bies.201200045","volume":"34","author":"ED Sverdlov","year":"2012","unstructured":"Sverdlov ED. Amedeo Avogadro\u2019s cry: what is 1 \u00b5g of exosomes? BioEssays. 2012;34(10):873\u20135.","journal-title":"BioEssays"},{"issue":"1","key":"2216_CR99","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1038\/s41467-019-12321-3","volume":"10","author":"W Fu","year":"2019","unstructured":"Fu W, et al. CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity. Nat Commun. 2019;10(1):4355.","journal-title":"Nat Commun"},{"issue":"12","key":"2216_CR100","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1182\/bloodadvances.2024014860","volume":"9","author":"P Lanuti","year":"2025","unstructured":"Lanuti P, et al. CD19.CAR T-cell\u2013derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy. Blood Adv. 2025;9(12):2907\u201319.","journal-title":"Blood Adv"},{"key":"2216_CR101","doi-asserted-by":"crossref","unstructured":"Storci G et al. CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells. J Clin Invest, 2024. 134(14).","DOI":"10.1172\/JCI173096"},{"issue":"4","key":"2216_CR102","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341\u20135.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2216_CR103","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12967-020-02622-3","volume":"18","author":"S Nikfarjam","year":"2020","unstructured":"Nikfarjam S, et al. Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine. J Translational Med. 2020;18(1):449.","journal-title":"J Translational Med"},{"key":"2216_CR104","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fimmu.2014.00556","volume":"5","author":"R Blazquez","year":"2014","unstructured":"Blazquez R, et al. Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells. Front Immunol. 2014;5:556.","journal-title":"Front Immunol"},{"issue":"11","key":"2216_CR105","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1089\/scd.2013.0479","volume":"23","author":"B Zhang","year":"2014","unstructured":"Zhang B, et al. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 2014;23(11):1233\u201344.","journal-title":"Stem Cells Dev"},{"key":"2216_CR106","doi-asserted-by":"publisher","first-page":"150021","DOI":"10.1016\/j.bbrc.2024.150021","volume":"717","author":"Y Deng","year":"2024","unstructured":"Deng Y, Liu Z, Lu M. Extracellular vesicles deviced from hypoxia-3D-GMSCs rescue the mitochondrial dysfunction of aging-GMSCs. Biochem Biophys Res Commun. 2024;717:150021.","journal-title":"Biochem Biophys Res Commun"},{"key":"2216_CR107","doi-asserted-by":"crossref","unstructured":"Burrello J et al. Stem Cell-Derived Extracellular Vesicles and Immune-Modulation. Front Cell Dev Biology, 2016. Volume 4\u20132016.","DOI":"10.3389\/fcell.2016.00083"},{"key":"2216_CR108","doi-asserted-by":"publisher","first-page":"102215","DOI":"10.1016\/j.mtbio.2025.102215","volume":"34","author":"P Shen","year":"2025","unstructured":"Shen P, et al. Genetically engineered MSC-derived hybrid cellular vesicles for ROS-scavenging and mitochondrial homeostasis in hepatic ischemia-reperfusion injury. Mater Today Bio. 2025;34:102215.","journal-title":"Mater Today Bio"},{"issue":"1","key":"2216_CR109","first-page":"63","volume":"9","author":"L Ye","year":"2013","unstructured":"Ye L, Swingen C, Zhang J. Induced pluripotent stem cells and their potential for basic and clinical sciences. Curr Cardiol Rev. 2013;9(1):63\u201372.","journal-title":"Curr Cardiol Rev"},{"issue":"6","key":"2216_CR110","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s12276-025-01465-6","volume":"57","author":"K Lv","year":"2025","unstructured":"Lv K, et al. Extracellular vesicles derived from lung M2 macrophages enhance group 2 innate lymphoid cells function in allergic airway inflammation. Exp Mol Med. 2025;57(6):1202\u201315.","journal-title":"Exp Mol Med"},{"issue":"10","key":"2216_CR111","doi-asserted-by":"publisher","first-page":"e0164696","DOI":"10.1371\/journal.pone.0164696","volume":"11","author":"CYY Loh","year":"2016","unstructured":"Loh CYY, et al. Episomal Induced Pluripotent Stem Cells Promote Functional Recovery of Transected Murine Peripheral Nerve. PLoS ONE. 2016;11(10):e0164696.","journal-title":"PLoS ONE"},{"issue":"2","key":"2216_CR112","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/CIRCRESAHA.116.309307","volume":"120","author":"JH Jung","year":"2017","unstructured":"Jung JH, Fu X, Yang PC. Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases. Circ Res. 2017;120(2):407\u201317.","journal-title":"Circ Res"},{"issue":"1","key":"2216_CR113","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13287-025-04440-0","volume":"16","author":"SZA Malik","year":"2025","unstructured":"Malik SZA, et al. Stem cell derived exosome trilogy: an epic comparison of human MSCs, ESCs and iPSCs. Stem Cell Res Ther. 2025;16(1):318.","journal-title":"Stem Cell Res Ther"},{"key":"2216_CR114","doi-asserted-by":"publisher","first-page":"149296","DOI":"10.1016\/j.gene.2025.149296","volume":"944","author":"BR S","year":"2025","unstructured":"S BR, Dhar R, Devi A. Exosomes-mediated CRISPR\/Cas delivery: A cutting-edge frontier in cancer gene therapy. Gene. 2025;944:149296.","journal-title":"Gene"},{"key":"2216_CR115","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jconrel.2017.09.013","volume":"266","author":"SM Kim","year":"2017","unstructured":"Kim SM, et al. Cancer-derived exosomes as a delivery platform of CRISPR\/Cas9 confer cancer cell tropism-dependent targeting. J Control Release. 2017;266:8\u201316.","journal-title":"J Control Release"},{"issue":"4","key":"2216_CR116","doi-asserted-by":"publisher","first-page":"1700611","DOI":"10.1002\/advs.201700611","volume":"5","author":"Y Lin","year":"2018","unstructured":"Lin Y, et al. Exosome\u2013Liposome Hybrid Nanoparticles Deliver CRISPR\/Cas9 System in MSCs. Adv Sci. 2018;5(4):1700611.","journal-title":"Adv Sci"},{"key":"2216_CR117","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2020.04.052","volume":"324","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. A pH-responsive silica\u2013metal\u2013organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries. J Controlled Release. 2020;324:194\u2013203.","journal-title":"J Controlled Release"},{"key":"2216_CR118","doi-asserted-by":"crossref","unstructured":"Verma N, Arora S. Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions. Pharmaceutics, 2025. 17(8).","DOI":"10.3390\/pharmaceutics17080990"},{"issue":"8","key":"2216_CR119","doi-asserted-by":"publisher","first-page":"e13904","DOI":"10.1111\/cts.13904","volume":"17","author":"CK Wang","year":"2024","unstructured":"Wang CK, Tsai TH, Lee CH. Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci. 2024;17(8):e13904.","journal-title":"Clin Transl Sci"},{"issue":"8","key":"2216_CR120","doi-asserted-by":"publisher","first-page":"e70145","DOI":"10.1002\/jev2.70145","volume":"14","author":"C Humbert","year":"2025","unstructured":"Humbert C, et al. GMP-Compliant Process for the Manufacturing of an Extracellular Vesicles-Enriched Secretome Product Derived From Cardiovascular Progenitor Cells Suitable for a Phase I Clinical Trial. J Extracell Vesicles. 2025;14(8):e70145.","journal-title":"J Extracell Vesicles"},{"key":"2216_CR121","doi-asserted-by":"crossref","unstructured":"Wang Y et al. Trends in mesenchymal stem cell-derived extracellular vesicles clinical trials 2014\u20132024: is efficacy optimal in a narrow dose range? Front Med, 2025. Volume 12\u20132025.","DOI":"10.3389\/fmed.2025.1625787"},{"issue":"13","key":"2216_CR122","doi-asserted-by":"publisher","first-page":"e23751","DOI":"10.1096\/fj.202302590RRRRR","volume":"38","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. Bone marrow mesenchymal stem cell\u2013derived exosomes effectively ameliorate the outcomes of rats with acute graft-versus-host disease. FASEB J. 2024;38(13):e23751.","journal-title":"FASEB J"},{"key":"2216_CR123","doi-asserted-by":"crossref","unstructured":"Jafarabadi M, Khaledi A. Escherichia Coli Bloodstream Infections and Associated Antibiotic Resistance Pattern in Hematological Malignancy Populations, A Global Systematic Review EJMO, 2024. 8(1).","DOI":"10.14744\/ejmo.2024.79645"},{"issue":"6","key":"2216_CR124","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.chest.2023.06.024","volume":"164","author":"AL Lightner","year":"2023","unstructured":"Lightner AL, et al. Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19: A Randomized, Placebo-Controlled Dosing Clinical Trial. Chest. 2023;164(6):1444\u201353.","journal-title":"Chest"},{"issue":"3","key":"2216_CR125","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/ird3.77","volume":"2","author":"E Fu","year":"2024","unstructured":"Fu E, Li Z. Extracellular vesicles: A new frontier in the theranostics of cardiovascular diseases. iRADIOLOGY. 2024;2(3):240\u201359.","journal-title":"iRADIOLOGY"},{"key":"2216_CR126","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12935-020-01389-3","volume":"20","author":"S Vafaei","year":"2020","unstructured":"Vafaei S, et al. Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer. Cancer Cell Int. 2020;20:288.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"2216_CR127","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/bjc.2015.201","volume":"113","author":"T Matsumura","year":"2015","unstructured":"Matsumura T, et al. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br J Cancer. 2015;113(2):275\u201381.","journal-title":"Br J Cancer"},{"issue":"5","key":"2216_CR128","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.18632\/oncotarget.2462","volume":"6","author":"D Kumar","year":"2015","unstructured":"Kumar D, et al. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer. Oncotarget. 2015;6(5):3280\u201391.","journal-title":"Oncotarget"},{"issue":"5","key":"2216_CR129","doi-asserted-by":"publisher","first-page":"e0125625","DOI":"10.1371\/journal.pone.0125625","volume":"10","author":"Y Hu","year":"2015","unstructured":"Hu Y, et al. Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer. PLoS ONE. 2015;10(5):e0125625.","journal-title":"PLoS ONE"},{"issue":"6","key":"2216_CR130","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s13402-022-00711-7","volume":"45","author":"W-C Lin","year":"2022","unstructured":"Lin W-C, et al. Molecular actions of exosomes and their theragnostics in colorectal cancer: current findings and limitations. Cell Oncol. 2022;45(6):1043\u201352.","journal-title":"Cell Oncol"},{"issue":"1","key":"2216_CR131","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1021\/cr300213b","volume":"115","author":"EK Lim","year":"2015","unstructured":"Lim EK, et al. Nanomaterials for theranostics: recent advances and future challenges. Chem Rev. 2015;115(1):327\u201394.","journal-title":"Chem Rev"},{"key":"2216_CR132","doi-asserted-by":"crossref","unstructured":"Yang M et al. Engineered Exosomes-Based Photothermal Therapy with MRI\/CT Imaging Guidance Enhances Anticancer Efficacy through Deep Tumor Nucleus Penetration. Pharmaceutics, 2021. 13(10).","DOI":"10.3390\/pharmaceutics13101593"},{"key":"2216_CR133","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mri.2020.02.001","volume":"68","author":"T Liu","year":"2020","unstructured":"Liu T, et al. Visualization of exosomes from mesenchymal stem cells in vivo by magnetic resonance imaging. Magn Reson Imaging. 2020;68:75\u201382.","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"2216_CR134","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.7150\/thno.27891","volume":"9","author":"FN Faruqu","year":"2019","unstructured":"Faruqu FN, et al. Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal Approach. Theranostics. 2019;9(6):1666\u201382.","journal-title":"Theranostics"},{"key":"2216_CR135","doi-asserted-by":"crossref","unstructured":"Guerrini L et al. Surface-Enhanced Raman Scattering (SERS) Spectroscopy for Sensing and Characterization of Exosomes in Cancer Diagnosis. Cancers (Basel), 2021. 13(9).","DOI":"10.3390\/cancers13092179"},{"key":"2216_CR136","doi-asserted-by":"crossref","unstructured":"Liang H et al. Advances in the application of Raman spectroscopy in haematological tumours. Front Bioeng Biotechnol, 2023. Volume 10\u20132022.","DOI":"10.3389\/fbioe.2022.1103785"},{"key":"2216_CR137","unstructured":"Li Y et al. Label-free detection of exosomes from different cellular sources based on surface-enhanced Raman spectroscopy combined with machine learning models. arXiv preprint arXiv:2401.14104, 2024."},{"issue":"47","key":"2216_CR138","doi-asserted-by":"publisher","first-page":"30436","DOI":"10.1021\/acsomega.0c03813","volume":"5","author":"M Russo","year":"2020","unstructured":"Russo M, et al. Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling. ACS Omega. 2020;5(47):30436\u201343.","journal-title":"ACS Omega"},{"key":"2216_CR139","doi-asserted-by":"crossref","unstructured":"Liu Q et al. iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma. Front Oncol, 2022. Volume 12\u20132022.","DOI":"10.3389\/fonc.2022.822805"},{"key":"2216_CR140","doi-asserted-by":"crossref","unstructured":"Jung KO et al. Identification of Lymphatic and Hematogenous Routes of Rapidly Labeled Radioactive and Fluorescent Exosomes through Highly Sensitive Multimodal Imaging. Int J Mol Sci, 2020. 21(21).","DOI":"10.3390\/ijms21217850"},{"key":"2216_CR141","doi-asserted-by":"crossref","unstructured":"Gulati R et al. Exosomes as Theranostic Targets: Implications for the Clinical Prognosis of Aggressive Cancers. Front Mol Biosci, 2022. Volume 9\u20132022.","DOI":"10.3389\/fmolb.2022.890768"},{"issue":"1","key":"2216_CR142","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-025-02271-4","volume":"24","author":"F Wang","year":"2025","unstructured":"Wang F, et al. Identification of blood-derived exosomal tumor RNA signatures as noninvasive diagnostic biomarkers for multi-cancer: a multi-phase, multi-center study. Mol Cancer. 2025;24(1):60.","journal-title":"Mol Cancer"},{"issue":"3","key":"2216_CR143","first-page":"100190","volume":"4","author":"S Yerukala Sathipati","year":"2023","unstructured":"Yerukala Sathipati S, et al. Artificial intelligence-driven pan-cancer analysis reveals miRNA signatures for cancer stage prediction. HGG Adv. 2023;4(3):100190.","journal-title":"HGG Adv"},{"key":"2216_CR144","doi-asserted-by":"crossref","unstructured":"Koumpis E et al. The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma. Biomedicines, 2024. 12(12).","DOI":"10.3390\/biomedicines12122658"},{"key":"2216_CR145","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1016\/j.csbj.2022.08.042","volume":"20","author":"CH Liu","year":"2022","unstructured":"Liu CH, et al. Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma. Comput Struct Biotechnol J. 2022;20:4626\u201335.","journal-title":"Comput Struct Biotechnol J"},{"key":"2216_CR146","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1016\/j.csbj.2021.10.009","volume":"19","author":"C Caudai","year":"2021","unstructured":"Caudai C, et al. AI applications in functional genomics. Comput Struct Biotechnol J. 2021;19:5762\u201390.","journal-title":"Comput Struct Biotechnol J"},{"issue":"9","key":"2216_CR147","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/bios15090610","volume":"15","author":"Y Chen","year":"2025","unstructured":"Chen Y, et al. Deep Learning-Driven Multimodal Integration of miRNA and Radiomic for Lung Cancer Diagnosis. Biosensors. 2025;15(9):610.","journal-title":"Biosensors"},{"issue":"8","key":"2216_CR148","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.ejca.2013.01.017","volume":"49","author":"K O\u2019Brien","year":"2013","unstructured":"O\u2019Brien K, et al. Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. Eur J Cancer. 2013;49(8):1845\u201359.","journal-title":"Eur J Cancer"},{"key":"2216_CR149","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuroscience.2025.10.054","volume":"591","author":"X Wang","year":"2025","unstructured":"Wang X, et al. XGboost with multi-feature fusion for hemodynamic state prediction. Neuroscience. 2025;591:63\u201375.","journal-title":"Neuroscience"},{"key":"2216_CR150","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bioactmat.2025.03.023","volume":"51","author":"A Thakur","year":"2025","unstructured":"Thakur A, et al. Quantum machine learning-based electrokinetic mining for the identification of nanoparticles and exosomes with minimal training data. Bioactive Mater. 2025;51:414\u201330.","journal-title":"Bioactive Mater"},{"key":"2216_CR151","doi-asserted-by":"publisher","first-page":"131776","DOI":"10.1016\/j.neucom.2025.131776","volume":"659","author":"J Yuan","year":"2026","unstructured":"Yuan J, et al. A lightweight dual path Kolmogorov-Arnold convolution network for medical optical image segmentation. Neurocomputing. 2026;659:131776.","journal-title":"Neurocomputing"},{"key":"2216_CR152","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jconrel.2024.10.065","volume":"376","author":"R Eugster","year":"2024","unstructured":"Eugster R, et al. Leveraging machine learning to streamline the development of liposomal drug delivery systems. J Controlled Release. 2024;376:1025\u201338.","journal-title":"J Controlled Release"},{"issue":"27","key":"2216_CR153","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.2174\/0109298673319827240812052102","volume":"32","author":"RMR Kumar","year":"2025","unstructured":"Kumar RMR. Exosome-Machine Learning Integration in Biomedicine: Advancing Diagnosis and Biomarker Discovery. Curr Med Chem. 2025;32(27):5760\u201371.","journal-title":"Curr Med Chem"},{"issue":"7","key":"2216_CR154","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol. 2021;16(7):748\u201359.","journal-title":"Nat Nanotechnol"},{"key":"2216_CR155","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/IJN.S264498","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, et al. Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications. Int J Nanomed. 2020;15:6917\u201334.","journal-title":"Int J Nanomed"},{"issue":"16","key":"2216_CR156","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785\u201391.","journal-title":"J Comput Chem"},{"issue":"7873","key":"2216_CR157","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583\u20139.","journal-title":"Nature"},{"key":"2216_CR158","doi-asserted-by":"publisher","first-page":"7231","DOI":"10.3390\/ijms25137231","volume":"25","author":"N Martarelli","year":"2024","unstructured":"Martarelli N, et al. Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen Receptors. Int J Mol Sci. 2024;25:7231.","journal-title":"Int J Mol Sci"},{"key":"2216_CR159","doi-asserted-by":"crossref","unstructured":"Lee SJ et al. Design and Prediction of Aptamers Assisted by In Silico Methods. Biomedicines, 2023. 11(2).","DOI":"10.3390\/biomedicines11020356"},{"key":"2216_CR160","doi-asserted-by":"publisher","first-page":"100223","DOI":"10.1016\/j.medidd.2025.100223","volume":"28","author":"I Pathan","year":"2025","unstructured":"Pathan I, et al. Revolutionizing pharmacology: AI-powered approaches in molecular modeling and ADMET prediction. Med Drug Discovery. 2025;28:100223.","journal-title":"Med Drug Discovery"},{"key":"2216_CR161","first-page":"100576","volume":"17","author":"G Obaido","year":"2024","unstructured":"Obaido G, et al. Supervised machine learning in drug discovery and development: Algorithms, applications, challenges, and prospects. Mach Learn Appl. 2024;17:100576.","journal-title":"Mach Learn Appl"},{"issue":"1","key":"2216_CR162","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1021\/acs.nanolett.8b02689","volume":"19","author":"Z Li","year":"2019","unstructured":"Li Z, et al. In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR\/dCas9. Nano Lett. 2019;19(1):19\u201328.","journal-title":"Nano Lett"},{"issue":"1","key":"2216_CR163","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41467-020-14957-y","volume":"11","author":"P Gee","year":"2020","unstructured":"Gee P, et al. Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping. Nat Commun. 2020;11(1):1334.","journal-title":"Nat Commun"},{"key":"2216_CR164","doi-asserted-by":"publisher","first-page":"123752","DOI":"10.1016\/j.lfs.2025.123752","volume":"375","author":"V Picchio","year":"2025","unstructured":"Picchio V, et al. The emerging role of artificial intelligence applied to exosome analysis: from cancer biology to other biomedical fields. Life Sci. 2025;375:123752.","journal-title":"Life Sci"},{"issue":"1","key":"2216_CR165","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10238-025-01686-z","volume":"25","author":"AK Bishoyi","year":"2025","unstructured":"Bishoyi AK, et al. Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation. Clin Experimental Med. 2025;25(1):166.","journal-title":"Clin Experimental Med"},{"issue":"5","key":"2216_CR166","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","volume":"20","author":"S M\u00e9ndez-Ferrer","year":"2020","unstructured":"M\u00e9ndez-Ferrer S, et al. Bone marrow niches in haematological malignancies. Nat Rev Cancer. 2020;20(5):285\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2216_CR167","doi-asserted-by":"publisher","first-page":"e70064","DOI":"10.1002\/jex2.70064","volume":"4","author":"A Brent","year":"2025","unstructured":"Brent A, Shirmast P, McMillan NAJ. Extracellular Vesicle Lipids and Their Role in Delivery. J Extracell Biology. 2025;4(6):e70064.","journal-title":"J Extracell Biology"},{"issue":"1","key":"2216_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm16010001","volume":"16","author":"AR Canestrale","year":"2026","unstructured":"Canestrale AR, et al. Targeted Hepatic Delivery of Bioactive Molecules via Nanovesicles: Recent Developments and Emerging Directions. J Personalized Med. 2026;16(1):1.","journal-title":"J Personalized Med"},{"issue":"1","key":"2216_CR169","first-page":"20240248","volume":"6","author":"H Zhang","year":"2026","unstructured":"Zhang H, et al. Surface Charge-Determined Protein Coronas of Nanoparticles Control Endothelial Cells Uptake Under Low Magnitude Shear Stress. Explor (Beijing). 2026;6(1):20240248.","journal-title":"Explor (Beijing)"},{"issue":"1","key":"2216_CR170","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.1002\/wnan.1835","volume":"15","author":"KP De Sousa","year":"2023","unstructured":"De Sousa KP, et al. Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(1):e1835.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"1","key":"2216_CR171","doi-asserted-by":"publisher","first-page":"e12033","DOI":"10.1002\/jev2.12033","volume":"10","author":"VVT Nguyen","year":"2020","unstructured":"Nguyen VVT, et al. Functional assays to assess the therapeutic potential of extracellular vesicles. J Extracell Vesicles. 2020;10(1):e12033.","journal-title":"J Extracell Vesicles"},{"key":"2216_CR172","doi-asserted-by":"crossref","unstructured":"Wiest EF et al. Developing a novel potency assay to assess bone marrow-derived extracellular vesicles. Cytotherapy, 2024. 26(6, Supplement): p. S89.","DOI":"10.1016\/j.jcyt.2024.03.169"},{"key":"2216_CR173","doi-asserted-by":"crossref","unstructured":"Wiest EF, Zubair AC. Generation of Current Good Manufacturing Practices-Grade Mesenchymal Stromal Cell-Derived Extracellular Vesicles Using Automated Bioreactors. Biology (Basel), 2025. 14(3).","DOI":"10.3390\/biology14030313"},{"key":"2216_CR174","doi-asserted-by":"publisher","first-page":"100278","DOI":"10.1016\/j.jlb.2024.100278","volume":"6","author":"A Thakur","year":"2024","unstructured":"Thakur A, Rai D. Global requirements for manufacturing and validation of clinical grade extracellular vesicles. J Liquid Biopsy. 2024;6:100278.","journal-title":"J Liquid Biopsy"},{"key":"2216_CR175","doi-asserted-by":"publisher","first-page":"106850","DOI":"10.1016\/j.jddst.2025.106850","volume":"107","author":"T Geng","year":"2025","unstructured":"Geng T, et al. Preservation of extracellular vesicles for drug delivery: A comparative evaluation of storage buffers. J Drug Deliv Sci Technol. 2025;107:106850.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"2216_CR176","doi-asserted-by":"publisher","first-page":"256","DOI":"10.7150\/ntno.51676","volume":"5","author":"AA Khan","year":"2021","unstructured":"Khan AA, R TMdR. Radiolabelling of Extracellular Vesicles for PET and SPECT imaging. Nanotheranostics. 2021;5(3):256\u201374.","journal-title":"Nanotheranostics"},{"issue":"10","key":"2216_CR177","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1021\/acs.bioconjchem.9b00587","volume":"30","author":"S Shi","year":"2019","unstructured":"Shi S, et al. Copper-64 Labeled PEGylated Exosomes for In Vivo Positron Emission Tomography and Enhanced Tumor Retention. Bioconjug Chem. 2019;30(10):2675\u201383.","journal-title":"Bioconjug Chem"},{"issue":"4","key":"2216_CR178","doi-asserted-by":"publisher","first-page":"684","DOI":"10.20517\/evcna.2023.49","volume":"4","author":"Y Shi","year":"2023","unstructured":"Shi Y, et al. Research progress in in vivo tracing technology for extracellular vesicles. Extracell Vesicles Circ Nucl Acids. 2023;4(4):684\u201397.","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"2216_CR179","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1016\/j.csbj.2025.06.014","volume":"27","author":"L Xu","year":"2025","unstructured":"Xu L, Li J, Gong W. Applications of machine learning-assisted extracellular vesicles analysis technology in tumor diagnosis. Comput Struct Biotechnol J. 2025;27:2460\u201372.","journal-title":"Comput Struct Biotechnol J"},{"issue":"8","key":"2216_CR180","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jcyt.2025.05.003","volume":"27","author":"V Di Cerbo","year":"2025","unstructured":"Di Cerbo V, et al. Artificial intelligence, machine learning, and digitalization systems in the cell and gene therapy sector: a guidance document from the ISCT industry committees. Cytotherapy. 2025;27(8):903\u20139.","journal-title":"Cytotherapy"},{"issue":"5","key":"2216_CR181","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.7150\/ijbs.92988","volume":"20","author":"WX Xu","year":"2024","unstructured":"Xu WX, et al. The Burgeoning Significance of Liquid-Liquid Phase Separation in the Pathogenesis and Therapeutics of Cancers. Int J Biol Sci. 2024;20(5):1652\u201368.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2216_CR182","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13287-024-03785-2","volume":"15","author":"M Ackermann","year":"2024","unstructured":"Ackermann M, et al. Standardized generation of human iPSC-derived hematopoietic organoids and macrophages utilizing a benchtop bioreactor platform under fully defined conditions. Stem Cell Res Ther. 2024;15(1):171.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"2216_CR183","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/cancers11050640","volume":"11","author":"J Yoo","year":"2019","unstructured":"Yoo J, et al. Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems. Cancers. 2019;11(5):640.","journal-title":"Cancers"},{"key":"2216_CR184","doi-asserted-by":"crossref","unstructured":"Molina Diaz BI et al. Engineering stimuli-responsive extracellular vesicles for enhanced anticancer therapeutics. Curr Opin Biomed Eng, 2026. 37.","DOI":"10.1016\/j.cobme.2025.100634"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02216-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02216-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02216-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:01:52Z","timestamp":1784577712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02216-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":184,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2216"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02216-1","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"274"}}